Latest From Biotech Now

Psoriasis Patients Flock to Social Media for Practical Info

Infographic

About eight in 10 psoriasis patients who use health care social networks say they do so primarily to learn how others manage their disease, and get practical tips and advice they couldn’t find elsewhere, according to a survey conducted by the National Psoriasis Foundation, Manhattan Research and Inspire, a company that builds and manages online patient communities. The millions of people with psoriasis, including the one million visitors to TalkPsoriasis in 2012, are not alone Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Face of a Giant Agribusiness

Corn

One of the more surprising items I saw in the media recently was on the Huffington Post blog. The HuffPost blog promises “fresh takes,” but this outlet is often critical of mainstream agriculture and large-scale food production – ironically, the very essence of how we feed 7 billion people in this world. But this post from Noah Hultgren, a young corn farmer from Kandiyohi County, Minnesota, puts a fresh face on mainstream agriculture and large-scale Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

The Michael J. Fox Foundation Launches New Funding Opportunities

Parkinson's Disease

The Michael J. Fox Foundation (MJFF) is committed to sharing the risk of drug development with researchers from academia and industry alike in order to keep promising research moving forward along the Parkinson’s disease (PD) drug pipeline. To date, MJFF has funded over $300 million in research, $83 million of which has been awarded to more than 180 unique, industry-led projects. On February 20, MJFF launched nine funding programs, three of which are new to Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

A Bright Future for Orphan Disease Indications

Chart

In celebration of National Rare Disease Day BIO’s Industry Analysis team took a look at recently-approved drugs in the BioMedTracker database with an orphan indication designation. Our research found that 2012 saw the greatest number of approvals of therapies for orphan indications going back all the way to 2000 (This count includes previously approved drugs with new, orphan indication approvals).   Overall, 24 therapies were approved in orphan indications last year, including drugs for Anthrax, Gaucher’s Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , ,

Navigating the Rare Disease World

Susan Ruediger

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled by the entrance of big pharmaceutical companies and U.S. legislation favoring development and coverage. This growth promises to improve the health of patients with debilitating and life-threatening disorders. Hoping to further the rare disease dialogue and relationship building opportunities, the 2013 Orphan Disease Forum will provide unique perspective on the orphan drug marketplace, regulatory considerations and much more. Operating within Read More >

Events  |  2 Comments  |  Email This Post
Tags: , , , , , , , ,